BioMarin Pharmaceuticals
BMRN
BMRN
526 hedge funds and large institutions have $13.4B invested in BioMarin Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 179 increasing their positions, 185 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
526
Holders Change
-8
Holders Change %
-1.5%
% of All Funds
9.26%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.09%
New
77
Increased
179
Reduced
185
Closed
82
Calls
$129M
Puts
$192M
Net Calls
-$62.4M
Net Calls Change
-$134M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$155M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$141M |
| 3 |
Parnassus Investments
San Francisco,
California
|
+$88M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$56.2M |
| 5 |
MNG
Manning & Napier Group
Fairport,
New York
|
+$46.9M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$103M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$87.1M |
| 3 |
ClearBridge Investments
New York
|
-$76.9M |
| 4 |
BlackRock
New York
|
-$58.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$52.4M |
